Samsung Biologics
Samsung Biologics union ends five-day strike, launches work-to-rule campaign
Rapporté par l'IA Image générée par IA
Unionized workers at Samsung Biologics ended their historic five-day general strike on Wednesday and shifted to a work-to-rule campaign to sustain pressure over pay demands. A one-on-one meeting with management is set for later Wednesday, followed by a three-way session with the labor ministry on Friday, amid ongoing disagreements.
Samsung Biologics' labor union, on strike since Friday in its first-ever walkout, agreed to resume negotiations with management on Monday under mediation by the Jungbu regional employment and labor office. Around 2,800 of 4,000 unionized workers are participating as the action enters its third day, with the union planning to continue until Tuesday.
Rapporté par l'IA
Unionized workers at Samsung Biologics, the biotech arm of Samsung Group, extended their historic first strike since the company's 2011 founding into a second day on May 2, 2026. The walkout over wages and other issues shows no signs of resolution after the Friday launch.